Related Experiment Video
Updated: Jan 31, 2026

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
Melatonin: Another avenue for treating osteoporosis?
Tian Li1,2, Shuai Jiang3, Chenxi Lu1
1Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Faculty of Life Sciences, Northwest University, Xi'an, China.
Melatonin, a molecule regulating circadian rhythms, shows potential in treating osteoporosis by both preventing bone loss and promoting new bone growth. Lower melatonin levels are linked to age-related bone density reduction.
Area of Science:
- Endocrinology
- Bone Biology
- Chronobiology
Background:
- Melatonin is a key regulator of circadian rhythms in vertebrates.
- Melatonin deficiency is linked to various health issues, including insomnia, cancer, and cardiovascular/neurodegenerative diseases.
- Evidence suggests melatonin's role in maintaining bone metabolism homeostasis, with age-related declines potentially contributing to osteoporosis.
Purpose of the Study:
- To investigate the role of melatonin in bone metabolism.
- To explore melatonin's potential as a biomarker for osteoporosis detection and prevention.
- To evaluate melatonin's therapeutic potential for osteoporosis.
Main Methods:
- Review of existing evidence on melatonin's effects on bone metabolism.
- Analysis of melatonin's proposed mechanisms of action, including receptor activation and gene expression modulation.
- Comparison of melatonin's effects with conventional osteoporosis treatments.
Main Results:
- Melatonin deficiency is associated with age-related bone loss and osteoporosis.
- Melatonin demonstrates a dual action: suppressing bone resorption and promoting bone formation.
- Mechanistically, melatonin activates the MT2 receptor, upregulating osteogenic genes (ALP, BMP2, BMP6, osteocalcin, osteoprotegerin) and inhibiting the RANKL pathway to reduce osteolysis.
Conclusions:
- Serum melatonin levels may serve as a biomarker for early osteoporosis detection and prevention.
- Melatonin exhibits a unique therapeutic profile, promoting osteogenesis and inhibiting osteolysis.
- Melatonin presents a promising novel therapeutic agent for the prevention and treatment of osteoporosis.
More Related Videos
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Types of Hormones
Gene Therapy
Induced Pluripotent Stem Cells
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...